These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8110676)

  • 1. Immunohistochemical analysis of lattice corneal dystrophies types I and II.
    Kivelä T; Tarkkanen A; McLean I; Ghiso J; Frangione B; Haltia M
    Br J Ophthalmol; 1993 Dec; 77(12):799-804. PubMed ID: 8110676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome.
    Kivelä T; Tarkkanen A; Frangione B; Ghiso J; Haltia M
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3759-69. PubMed ID: 8088963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis.
    Loeffler KU; Edward DP; Tso MO
    Am J Ophthalmol; 1992 May; 113(5):546-54. PubMed ID: 1315488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies.
    Rodrigues MM; Rajagopalan S; Jones K; Nirankari V; Wisniewski T; Frangione B; Gorevic PD
    Am J Ophthalmol; 1993 May; 115(5):644-52. PubMed ID: 7683843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural localization of gelsolin in lattice corneal dystrophy type I.
    Longanesi L; Cavallini GM; Iammarino A; Vaccina F; Guerra R; De Pol A
    Ophthalmologica; 1998; 212(6):415-21. PubMed ID: 9787234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical corneal dystrophy with stromal amyloid deposits.
    Malbran ES; Meijide RF; Croxatto JO
    Cornea; 1988; 7(3):210-3. PubMed ID: 3048883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unilateral type III (Hida) lattice stromal corneal dystrophy].
    Seitz B; Weidle E; Naumann GO
    Klin Monbl Augenheilkd; 1993 Oct; 203(4):279-85. PubMed ID: 8114470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type).
    Maury CP; Liljeström M; Boysen G; Törnroth T; de la Chapelle A; Nurmiaho-Lassila EL
    J Clin Pathol; 2000 Feb; 53(2):95-9. PubMed ID: 10767822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome).
    Purcell JJ; Rodrigues M; Chishti MI; Riner RN; Dooley JM
    Ophthalmology; 1983 Dec; 90(12):1512-7. PubMed ID: 6610849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Haltia M
    Handb Clin Neurol; 2013; 115():659-81. PubMed ID: 23931809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lattice corneal dystrophy type II: clinical, pathologic, and molecular study in a Spanish family.
    Huerva V; Velasco A; Sánchez MC; Mateo AJ; Matías-Guiu X
    Eur J Ophthalmol; 2007; 17(3):424-9. PubMed ID: 17534828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.
    Cabral-Macias J; Garcia-Montaño LA; Pérezpeña-Díazconti M; Aguilar MC; Garcia G; Vencedor-Meraz CI; Graue-Hernandez EO; Chacón-Camacho OF; Zenteno JC
    Mol Vis; 2020; 26():345-354. PubMed ID: 32368002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic and immunochemical features of lattice corneal dystrophy type III.
    Hida T; Proia AD; Kigasawa K; Sanfilippo FP; Burchette JL; Akiya S; Klintworth GK
    Am J Ophthalmol; 1987 Sep; 104(3):249-54. PubMed ID: 3498367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary gelsolin amyloidosis--40 years of Meretoja disease].
    Kiuru-Enari S; Haltia M
    Duodecim; 2010; 126(10):1162-71. PubMed ID: 20597346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratoepithelin in secondary corneal amyloidosis.
    Suesskind D; Auw-Haedrich C; Schorderet DF; Munier FL; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):725-31. PubMed ID: 16331487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of the AA protein in lattice dystrophy.
    Wheeler GE; Eiferman RA
    Exp Eye Res; 1983 Feb; 36(2):181-6. PubMed ID: 6337859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in amyloid deposition in primary and recurrent corneal lattice dystrophy type 1.
    Snead DR; Mathews BN
    Cornea; 2002 Apr; 21(3):308-11. PubMed ID: 11917182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome).
    Carrwik C; Stenevi U
    Acta Ophthalmol; 2009 Nov; 87(8):813-9. PubMed ID: 19832730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.